Canada: Back To Basic: US Supreme Court To Hear Amgen And Clarify "Fraud-On-The-Market" Reliance Presumption In Class Actions

The Supreme Court of the United States has announced it will hear the appeal in Amgen Inc. v. Connecticut Retirement Plans and Trust Funds, setting the stage for an important clarification of the use of the "fraud-on-the-market" reliance presumption in U.S. securities class actions. The Court first set out the presumption in its 1988 landmark decision in Basic Inc. v. Levinson, 485 U.S. 224 (1988). The Amgen decision will have an impact in Canada, where courts have grappled with the question of reliance in such cases. Generally, Canadian courts have been sceptical about importing a "fraud-on-the-market" approach, but recent case law has created some ambiguity about what evidence is necessary to prove reliance in common law misrepresentation claims. The Amgen appeal decision may help focus key aspects of that debate.


Any securities class action is ultimately premised on the idea that a material misrepresentation caused a loss to plaintiffs who relied upon it in deciding to trade on the securities market. Statutory causes of action, including those under Part XXIII of the Ontario Securities Act, may exist without regard to individual reliance, but a common law negligent misrepresentation claim in Canada is inherently linked to the notion of reliance, which must be considered both at the duty of care stage – asking whether reliance was foreseeable and would have been reasonable – and in assessing whether there was, in fact, reliance on the misrepresentation in question that caused the loss. As the Supreme Court of Canada noted in Hercules Managements, reliance is engaged from the very first step of analysis: it is the very "reliance by the plaintiff on the defendant's words" that creates the necessary relationship of proximity that permits a duty of care to exist. In its recent decision in Sharbern Holding, the Supreme Court of Canada again re-affirmed the need for actual reliance, and clarified that this requirement cannot be waived by deemed reliance pursuant to a statute.

In the United States, claims under the Securities Exchange Act of 1934 and the SEC's Rule 10b-5 also require the plaintiffs to demonstrate reliance on the allegedly untrue statement or material omission. Given that common issues must predominate over individual issues, class action certification in a securities case will therefore require a finding that the element of reliance is common to the class. In Basic Inc., the U.S. Supreme Court found that it was appropriate to adopt a rebuttable presumption of reliance in such cases, given the difficulties for plaintiff investors to otherwise prove individual reliance. The Court found that the presumption is appropriate given the nature of modern securities trading:

The modern securities markets, literally involving millions of shares changing hands daily, differ from the face-to-face transactions contemplated by early fraud cases, and our understanding of Rule 10b-5's reliance requirement must encompass these differences.

The Court thereby relieved the plaintiff of an "unnecessarily unrealistic evidentiary burden." Instead of having to demonstrate individual reliance, the plaintiff could rely on the presumption that, if the relevant security traded in an efficient market, its market price would reflect all publicly available information, including any misrepresentations. Instead of proving that he or she relied on the misrepresentation, the plaintiff can effectively benefit from the market as a whole having relied on it in determining the share price.

Nearly twenty-five years later, Amgen provides the Court with an opportunity to reconsider two aspects of the "fraud-on-the-market" presumption and how it operates in the class action context. First, the Court will determine whether or not the plaintiffs must demonstrate at the certification stage that the alleged misrepresentation is material before permitting certification on the basis of the "fraud-on-the-market" theory. Second, the Court will consider whether defendants should be permitted to lead evidence rebutting the applicability of the presumption at the certification stage, or whether this effectively amounts to an assessment of the merits of the plaintiffs' claim.

Decisions Below

Amgen Inc. is a pharmaceutical company. The plaintiff, Connecticut Retirement Plans and Trust Funds ("Connecticut Retirement"), claims Amgen made certain misrepresentations about its products. It alleges that Amgen's share price was artificially inflated by these alleged misstatements and that, when disclosure was ultimately made, the drop in share price caused Connecticut Retirement significant losses. The district court certified the class action, in part on the basis that reliance was a common issue by operation of the "fraud-on-the-market" presumption.  Amgen had conceded that the market in which its shares traded was an efficient one, but argued that the truth that the plaintiff claimed had been concealed by the misrepresentations had in fact already entered the market at the relevant time. The district court refused to permit Amgen to lead evidence on this argument (sometimes referred to as the "truth-on-the-market" defence), finding that it was an issue for trial. Amgen also argued that the plaintiffs had failed to prove the materiality of the alleged misrepresentation, but the district court found that the plaintiffs merely had to allege materiality rather than prove it in order to engage the presumption.

On appeal, the United States Court of Appeals for the Ninth Circuit affirmed the decision and enthusiastically endorsed a sweeping interpretation of the "fraud-on-the-market" presumption. On the question of what the plaintiff must show about the materiality of the alleged misrepresentation, the Court found that plaintiffs need only "allege materiality with sufficient plausibility" in order to get the benefit of the presumption of reliance. The Court found that Amgen's argument that the alleged misrepresentation was immaterial was effectively an argument on the merits. If it were true, none of the plaintiffs would have a claim and therefore it did not affect whether certification was appropriate. In effect, the Court found that Amgen's claim of immateriality was too good to be true at the certification stage and should be left for trial.

On the question of whether Amgen should have been permitted to lead evidence to support a "truth-on-the-market" defence, the Court affirmed the district court's decision to deny it this opportunity. The Court of Appeals found that this was simply another way to consider an argument about the materiality (or lack thereof) of the alleged misrepresentations, and that materiality is a merits issue best left for trial or a summary judgment motion.

Potential Significance

The Court of Appeals for the Ninth Circuit's approach in Amgen has left only a very narrow window for defendants in that circuit seeking to rebut the "fraud-on-the-market" presumption. Defendants are permitted to argue that the market is not an efficient one, or to argue that the alleged misrepresentations were not publicly made, but are otherwise unable to lead any evidence to suggest that the market price was not affected because the alleged misrepresentations were insignificant or already known to the market. This interpretation deprives defendants of any opportunity at the certification stage to demonstrate that the alleged misrepresentations had no effect on the market price because the market was indifferent to them. This would seem to have proven Justice White correct in his dissent in Basic, where he noted that while rebutting "fraud-on-the-market" was possible in theory, "such rebuttal is virtually impossible in all but the most extraordinary case."

In Amgen, the Supreme Court accepted two issues for review:

  1. whether proof of materiality is necessary before the "fraud-on-the-market" presumption is engaged as the basis for certification of a class action; and
  2. whether the defendant must be given an opportunity to rebut the presumption's applicability on the facts of the case.

Each of these will give the Supreme Court an opportunity to address whether the approach taken in the Ninth Circuit appropriately considers the interests of defendants who have an argument, on the facts, that the alleged misrepresentation likely had no impact whatsoever on the share price. Given that share prices rise and fall for a variety of reasons, where defendants have compelling evidence about the immateriality of the alleged misrepresentation, it would seem appropriate to allow them the opportunity to lead it before the court decides whether a class action should be certified. Circuit courts presently fall into two distinct camps on these questions, with three circuits now clearly invoking the "fraud-on-the-market" presumption without any requirement that materiality have been proven.

The Amgen appeal will be watched closely in Canada. While Canadian courts have been sceptical of "fraud-on-the-market" either as a proper legal or factual presumption, there is nevertheless some ambiguity about its proper place in misrepresentation claims. In Carom v. Bre-X, Justice Winkler (as he then was) provided a thoughtful rejection of "fraud-on-the-market" as a legal or factual presumption that should apply in Canadian common law claims of fraudulent or negligent misrepresentation. Notwithstanding Carom, however, some courts have suggested it may be possible to find, on the particular facts of a case, that an "efficient market" operated in relation to the specific alleged misstatements at issue and that reliance by many plaintiffs could be inferred without evidence of individual reliance.

Given the Supreme Court of Canada's re-affirmation in Sharbern Holding of the need for "actual reliance" in common law misrepresentation claims, it will be interesting to see how lower courts apply this requirement in proposed securities class actions. Two recent developments suggest the implications of Sharbern are being felt.

In February, Leitch J. granted leave to appeal the decision in Arctic Glacier, in which the court had dismissed a defence motion to strike a pleading of negligent misrepresentation that failed to specifically plead detrimental reliance by individual plaintiffs. In part, the motions judge had relied on cases taking a relaxed approach to the reliance requirement at the certification stage and suggesting that reliance may be inferred on the facts. Leitch J. found that Sharbern "creates a correctness and conflict issue...which would benefit from appellate review."

Similarly, in a decision released yesterday, Strathy J. dismissed an attempt to certify detrimental reliance as a proposed common issue in Green v. Canadian Imperial Bank of Commerce, finding that Sharbern "has re-affirmed the need to establish reliance in a common law misrepresentation claim" and that the issue was not capable of resolution on a common basis. His Honour noted that "there is no authority to support the proposition that "fraud on the market" or the "efficient market" theory can supplant the need to prove individual reliance."

These recent cases suggest that courts in Ontario may be abandoning earlier attempts to create a distinction between a "legal" and "factual" presumption of reliance in such cases. This distinction was always tenuous, given that either formulation of the presumption depends on accepting that an efficient market hypothesis should drive not only judicial decision-making, but the very elements of the tort in question. While the Canadian discussion about the proper place ofmarket price theories in class action certification is ongoing, we can expect that protagonists on this side of the border will be listening carefully when the U.S. Supreme Court releases its decision in Amgen.

Case Information

Amgen Inc. v. Connecticut Retirement Plans and Trust Funds

U.S. Supreme Court Docket: 11-1085

Petition for a writ of certiorari granted: June 11, 2012

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.